- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- hetero-5-5-5-5-mer
- Ligands
- 5 x ZN: ZINC ION(Non-covalent)
- 5 x W11: 3-{3,5-DIMETHYL-4-[3-(3-METHYL-ISOXAZOL-5-YL)-PROPOXY]-PHENYL}-5-TRIFLUOROMETHYL-[1,2,4]OXADIAZOLE(Non-covalent)
W11.2: 17 residues within 4Å:- Chain A: I.98, L.100, I.122, M.124, Y.142, M.143, Y.144, A.166, S.167, V.168, F.179, L.181, L.184, Y.190, N.212, M.214, L.217
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:I.98, A:L.100, A:I.122, A:Y.144, A:Y.144, A:L.181, A:L.184, A:Y.190
- Water bridges: A:L.100
- pi-Stacking: A:Y.190
- Halogen bonds: A:A.166
W11.5: 17 residues within 4Å:- Chain E: I.98, L.100, I.122, M.124, Y.142, M.143, Y.144, A.166, S.167, V.168, F.179, L.181, L.184, Y.190, N.212, M.214, L.217
11 PLIP interactions:11 interactions with chain E- Hydrophobic interactions: E:I.98, E:L.100, E:I.122, E:Y.144, E:Y.144, E:L.181, E:L.184, E:Y.190
- Water bridges: E:L.100
- pi-Stacking: E:Y.190
- Halogen bonds: E:A.166
W11.8: 17 residues within 4Å:- Chain I: I.98, L.100, I.122, M.124, Y.142, M.143, Y.144, A.166, S.167, V.168, F.179, L.181, L.184, Y.190, N.212, M.214, L.217
11 PLIP interactions:11 interactions with chain I- Hydrophobic interactions: I:I.98, I:L.100, I:I.122, I:Y.144, I:Y.144, I:L.181, I:L.184, I:Y.190
- Water bridges: I:L.100
- pi-Stacking: I:Y.190
- Halogen bonds: I:A.166
W11.11: 17 residues within 4Å:- Chain M: I.98, L.100, I.122, M.124, Y.142, M.143, Y.144, A.166, S.167, V.168, F.179, L.181, L.184, Y.190, N.212, M.214, L.217
11 PLIP interactions:11 interactions with chain M- Hydrophobic interactions: M:I.98, M:L.100, M:I.122, M:Y.144, M:Y.144, M:L.181, M:L.184, M:Y.190
- Water bridges: M:L.100
- pi-Stacking: M:Y.190
- Halogen bonds: M:A.166
W11.14: 17 residues within 4Å:- Chain Q: I.98, L.100, I.122, M.124, Y.142, M.143, Y.144, A.166, S.167, V.168, F.179, L.181, L.184, Y.190, N.212, M.214, L.217
11 PLIP interactions:11 interactions with chain Q- Hydrophobic interactions: Q:I.98, Q:L.100, Q:I.122, Q:Y.144, Q:Y.144, Q:L.181, Q:L.184, Q:Y.190
- Water bridges: Q:L.100
- pi-Stacking: Q:Y.190
- Halogen bonds: Q:A.166
- 5 x MYR: MYRISTIC ACID(Non-covalent)
MYR.3: 11 residues within 4Å:- Chain D: G.1, I.29, N.30
- Chain E: Y.6
- Chain H: Y.26, F.27, I.29
- Chain L: F.27
- Chain O: L.2
- Ligands: MYR.6, MYR.15
5 PLIP interactions:1 interactions with chain L, 2 interactions with chain H, 1 interactions with chain O, 1 interactions with chain D- Hydrophobic interactions: L:F.27, H:F.27, H:I.29, O:L.2, D:I.29
MYR.6: 11 residues within 4Å:- Chain H: G.1, I.29, N.30
- Chain I: Y.6
- Chain L: Y.26, F.27, I.29
- Chain P: F.27
- Chain S: L.2
- Ligands: MYR.3, MYR.9
5 PLIP interactions:2 interactions with chain L, 1 interactions with chain S, 1 interactions with chain P, 1 interactions with chain H- Hydrophobic interactions: L:F.27, L:I.29, S:L.2, P:F.27, H:I.29
MYR.9: 11 residues within 4Å:- Chain C: L.2
- Chain L: G.1, I.29, N.30
- Chain M: Y.6
- Chain P: Y.26, F.27, I.29
- Chain T: F.27
- Ligands: MYR.6, MYR.12
5 PLIP interactions:2 interactions with chain P, 1 interactions with chain C, 1 interactions with chain L, 1 interactions with chain T- Hydrophobic interactions: P:F.27, P:I.29, C:L.2, L:I.29, T:F.27
MYR.12: 11 residues within 4Å:- Chain D: F.27
- Chain G: L.2
- Chain P: G.1, I.29, N.30
- Chain Q: Y.6
- Chain T: Y.26, F.27, I.29
- Ligands: MYR.9, MYR.15
5 PLIP interactions:1 interactions with chain D, 2 interactions with chain T, 1 interactions with chain P, 1 interactions with chain G- Hydrophobic interactions: D:F.27, T:F.27, T:I.29, P:I.29, G:L.2
MYR.15: 11 residues within 4Å:- Chain A: Y.6
- Chain D: Y.26, F.27, I.29
- Chain H: F.27
- Chain K: L.2
- Chain T: G.1, I.29, N.30
- Ligands: MYR.3, MYR.12
5 PLIP interactions:1 interactions with chain H, 2 interactions with chain D, 1 interactions with chain T, 1 interactions with chain K- Hydrophobic interactions: H:F.27, D:F.27, D:I.29, T:I.29, K:L.2
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, Y. et al., Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds. J.Virol. (2004)
- Release Date
- 2003-12-16
- Peptides
- coat protein VP1: AEIMQ
coat protein VP2: BFJNR
coat protein VP3: CGKOS
coat protein VP4: DHLPT - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
AI
AM
AQ
AB
BF
BJ
BN
BR
BC
CG
CK
CO
CS
CD
DH
DL
DP
DT
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- hetero-5-5-5-5-mer
- Ligands
- 5 x ZN: ZINC ION(Non-covalent)
- 5 x W11: 3-{3,5-DIMETHYL-4-[3-(3-METHYL-ISOXAZOL-5-YL)-PROPOXY]-PHENYL}-5-TRIFLUOROMETHYL-[1,2,4]OXADIAZOLE(Non-covalent)
- 5 x MYR: MYRISTIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, Y. et al., Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds. J.Virol. (2004)
- Release Date
- 2003-12-16
- Peptides
- coat protein VP1: AEIMQ
coat protein VP2: BFJNR
coat protein VP3: CGKOS
coat protein VP4: DHLPT - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
AI
AM
AQ
AB
BF
BJ
BN
BR
BC
CG
CK
CO
CS
CD
DH
DL
DP
DT
D